The role of Wnts in regulating anti-tumor immunity to immune checkpoint inhibitors (ICI), such as anti-PD1, anti-CTLA4, or anti-PD-L1. Consequence of blocking the Wnt/β-catenin (inhibitors as possible adjuvants) plus ICI on anti-tumor immune responses. This evidence concerns the gene CD274 and neoplasm.